loadpatents
name:-0.038499116897583
name:-0.027103900909424
name:-0.026876926422119
Sheng; Xiaohong Patent Filings

Sheng; Xiaohong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sheng; Xiaohong.The latest application filed is for "crystal form of tipifarnib and preparation method and pharmaceutical composition thereof".

Company Profile
24.27.32
  • Sheng; Xiaohong - Zhejiang CN
  • SHENG; Xiaohong - Hangzhou CN
  • Sheng; Xiaohong - Beachwood OH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fenofibrate crystalline form and manufacturing method thereof
Grant 11,427,528 - Shi , et al. August 30, 2
2022-08-30
Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereof
Grant 11,286,259 - Sheng , et al. March 29, 2
2022-03-29
ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof
Grant 11,236,073 - Sheng , et al. February 1, 2
2022-02-01
Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof
Grant 11,236,077 - Sheng , et al. February 1, 2
2022-02-01
Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereof
Grant 11,208,382 - Sheng , et al. December 28, 2
2021-12-28
Crystalline forms, preparation methods and pharmaceutical compositions of ozanimod
Grant 11,117,875 - Sheng , et al. September 14, 2
2021-09-14
Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyr- rolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereof
Grant 11,111,248 - Sheng , et al. September 7, 2
2021-09-07
Crystal Form Of Tipifarnib And Preparation Method And Pharmaceutical Composition Thereof
App 20210214335 - SHENG; Xiaohong ;   et al.
2021-07-15
Crystal Form Of Acp-196 And Method Of Treatment Thereof
App 20210188859 - SHENG; Xiaohong ;   et al.
2021-06-24
Crystal Form Of Abemaciclib Mesylate, Preparation Method Therefor And Pharmaceutical Composition Thereof
App 20210179585 - SHENG; Xiaohong ;   et al.
2021-06-17
Canagliflozin Monohydrate And Its Crystalline Forms, Preparation Methods And Uses Thereof
App 20210163457 - Sheng; Xiaoxia ;   et al.
2021-06-03
Fruquintinib Eutectic Crystal, Preparation Method Therefor, Composition, And Uses Thereof
App 20210155613 - SHENG; Xiaohong ;   et al.
2021-05-27
Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-p- yrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition
Grant 10,995,083 - Sheng , et al. May 4, 2
2021-05-04
Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof
Grant 10,954,223 - Sheng , et al. March 23, 2
2021-03-23
Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof
Grant 10,954,210 - Sheng , et al. March 23, 2
2021-03-23
Crystal form of ACP-196, preparation method therefor and pharmaceutical composition thereof
Grant 10,899,767 - Sheng , et al. January 26, 2
2021-01-26
Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereof
Grant 10,899,770 - Sheng , et al. January 26, 2
2021-01-26
Crystal Form Of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4h-pyr- Rolo[1,2-b]pyrazole, Preparation Method Therefor And Pharmaceutical Composition Thereof
App 20200399272 - SHENG; Xiaohong ;   et al.
2020-12-24
ABT-199 addition salt and crystal form thereof, preparation method thereof, and pharmaceutical composition thereof
Grant 10,759,798 - Sheng , et al. Sep
2020-09-01
Entinostat-containing Compound, Crystal Form Of Compound Thereof, And Preparation Method Therefor And Pharmaceutical Composition
App 20200270213 - SHENG; Xiaohong ;   et al.
2020-08-27
Co-crystals Of Ribociclib And Co-crystals Of Ribociclib Monosuccinate, Preparation Method Therefor, Compositions Thereof, And Us
App 20200262839 - SHENG; Xiaohong ;   et al.
2020-08-20
Odm-201 Crystalline Form, Preparation Method Therefor, And Pharmaceutical Composition Thereof
App 20200216422 - SHENG; Xiaohong ;   et al.
2020-07-09
Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereof
Grant 10,669,256 - Sheng , et al.
2020-06-02
Ozanimod Addition Salt Crystal, Preparation Method, Pharmaceutical Composition, And Uses
App 20200031784 - SHENG; Xiaohong ;   et al.
2020-01-30
Cocrystal Of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4h-p- Yrrole[1,2-b]pyrazole, Preparation Metho
App 20200017470 - SHENG; Xiaohong ;   et al.
2020-01-16
Crystal Form Of Acp-196, Preparation Method Therefor And Pharmaceutical Composition Thereof
App 20190382405 - SHENG; Xiaohong ;   et al.
2019-12-19
Crystal Form Of Acp-196 Salt And Preparation Method, Pharmaceutical Composition, And Use Thereof
App 20190375755 - SHENG; Xiaohong ;   et al.
2019-12-12
Crystal Form Of Tipifarnib And Preparation Method And Pharmaceutical Composition Thereof
App 20190345134 - SHENG; Xiaohong ;   et al.
2019-11-14
Canagliflozin Monohydrate And Its Crystalline Forms, Preparation Methods And Uses Thereof
App 20190315727 - Sheng; Xiaoxia ;   et al.
2019-10-17
Fenofibrate Crystalline Form And Manufacturing Method Thereof
App 20190270694 - SHI; Xiangjun ;   et al.
2019-09-05
Abt-199 Addition Salt And Crystal Form Thereof, Preparation Method Thereof, And Pharmaceutical Composition Thereof
App 20190248788 - SHENG; XIAOHONG ;   et al.
2019-08-15
Crystal Form Of Ozanimod, And Preparation Method And Pharmaceutical Composition Thereof
App 20190241530 - SHENG; Xiaohong ;   et al.
2019-08-08
Crystalline Form Of Receptor Agonist, And Manufacturing Method And Pharmaceutical Composition Thereof
App 20190233393 - SHENG; Xiaohong ;   et al.
2019-08-01
Crystalline form of oxazolidinone antibiotics and preparation method, composition and use thereof
Grant 10,189,870 - Sheng , et al. Ja
2019-01-29
Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof
Grant 10,174,010 - Sheng , et al. J
2019-01-08
Cocrystal of lorcaserin, preparation methods, pharmaceutical compositions and uses thereof
Grant 9,981,912 - Hu , et al. May 29, 2
2018-05-29
Crystal form of Dabrafenib mesylate and preparation method thereof
Grant 9,884,856 - Lao , et al. February 6, 2
2018-02-06
Cocrystal Of Lorcaserin, Preparation Methods, Pharmaceutical Compositions And Use Thereof (as Amended)
App 20170327467 - HU; Chenyang ;   et al.
2017-11-16
Crystalline forms of afatinib monomaleate, preparation methods and pharmaceutical compositions thereof
Grant 9,708,301 - Sheng , et al. July 18, 2
2017-07-18
Canagliflozin Monohydrate And Its Crystalline Forms, Preparation Methods And Uses Thereof
App 20170145000 - SHENG; Xiaoxia ;   et al.
2017-05-25
Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage
Grant 9,562,024 - Song , et al. February 7, 2
2017-02-07
Crystalline Form Of Oxazolidinone Antibiotics And Preparation Method, Composition And Use Thereof
App 20170008919 - SHENG; Xiaoxia ;   et al.
2017-01-12
Novel Crystal Form of Dabrafenib Mesylate and Preparation Method Thereof
App 20160368909 - LAO; Haiping ;   et al.
2016-12-22
Inhibitor crystalline form and preparation method and use thereof
Grant 9,518,059 - Zhang , et al. December 13, 2
2016-12-13
Crystal form of dabrafenib and preparation method and use thereof
Grant 9,458,149 - Lao , et al. October 4, 2
2016-10-04
Crystal form of dabrafenib mesylate and preparation method thereof
Grant 9,453,011 - Lao , et al. September 27, 2
2016-09-27
Vortioxetine Salt And Crystal Thereof, Their Preparation Method, Pharmaceutical Compositions And Usage
App 20160214950 - Song; Xiaoye ;   et al.
2016-07-28
Crystal Form of Dabrafenib and Preparation Method and Use Thereof
App 20160207911 - LAO; Haiping ;   et al.
2016-07-21
Crystalline Forms of Afatinib Monomaleate, Preparation Methods and Pharmaceutical Compositions Thereof
App 20160207907 - Sheng; Xiaohong ;   et al.
2016-07-21
Vortioxetine Salt And Crystal Thereof, Their Preparation Method, Pharmaceutical Compositions And Usage
App 20160200698 - Song; Xiaoye ;   et al.
2016-07-14
Crystal form of Dabrafenib and preparation method of use thereof
Grant 9,365,559 - Lao , et al. June 14, 2
2016-06-14
Inhibitor Crystalline Form and Preparation Method and Use Thereof
App 20160145258 - ZHANG; Zhonghua ;   et al.
2016-05-26
Novel Crystal Form of Dabrafenib Mesylate and Preparation Method Thereof
App 20160046615 - LAO; Haiping ;   et al.
2016-02-18
Solvate form M of trametinib dimethyl sulfoxide and methods of making and using thereof
Grant 9,181,243 - Hu , et al. November 10, 2
2015-11-10
Crystal Form of Dabrafenib and Preparation Method and Use Thereof
App 20150307484 - LAO; Haiping ;   et al.
2015-10-29
Solvate Form M Of Trametinib Dimethyl Sulfoxide And Methods Of Making And Using Thereof
App 20150152100 - HU; Chenyang ;   et al.
2015-06-04
Solid forms of an anti-HIV phosphoindole compound
Grant 8,470,870 - Moussa , et al. June 25, 2
2013-06-25
Solid Forms Of An Anti-hiv Phosphoindole Compound
App 20110039803 - Moussa; Adel M. ;   et al.
2011-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed